NSM becomes exclusive distributor for Ekso

By HME News Staff
Updated 10:01 AM CST, Mon February 10, 2025
NASHVILLE, Tenn. – National Seating & Mobility has partnered with Ekso Bionics Holdings to broaden access to Ekso’s Indego-powered exoskeleton device for individuals living with spinal cord injuries and other mobility challenges throughout North America. “NSM is committed to investing in resources and partnerships that enable us to bring the most advanced mobility and accessibility solutions to those we serve,” said Crispin Teufel, CEO of NSM. “We are proud to partner with Ekso Bionics to expand access to the life-changing Ekso Indego Personal device to those who rely on CRT equipment and can benefit from the mobility and therapy this innovative technology provides.” Ekso Indego Personal is a wearable lower extremity powered exoskeleton that enables many individuals living with SCIs the ability to stand and walk independently. CMS’s 2024 Home Health PPS rule added exoskeletons to Medicare’s brace benefit category, which expanded coverage of personal-use devices like the Esko Indego. “We are excited to expand the distribution of the Ekso Indego Personal device through this strategic commercial partnership with NSM,” commented Scott Davis, the Ekso’s CEO. “Both companies see a world where people have widespread access to innovative technologies that allow them to rethink their current physical limitation. We are looking forward to working with NSM to make that a reality. And as a fast-growing, well-established company in the CRT space, NSM’s proven expertise and robust infrastructure are well aligned with our growth strategy.”
Comments